CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![GettyImages-2257501711-lab-data-scientist-operations]( "Early-Phase Lab Data: Why It Breaks And How To Prevent Risk")
Early-Phase Lab Data: Why It Breaks And How To Prevent RiskLearn why lab data systems built quickly in early-phase trials tend to outlast their usefulness, quietly accumulating inconsistencies that surface only when scrutiny intensifies later in a study.
-
![data analysis safety, software overlay, cyber security coding-GettyImages-1552877787]( "Defining Meaningful Anti-Inflammatory Response: What Early Human Data Tells Us")
Defining Meaningful Anti-Inflammatory Response: What Early Human Data Tells UsControlled immune challenges link drug exposure to biological effects, helping refine dose selection, test mechanisms and support better decisions before patient trials.
-
![Artificial Intelligence, AI-GettyImages-2178269161]( "AI In Precision Medicine: From Predictive Insight To Operational Confidence In Complex Clinical Trials")
AI In Precision Medicine: From Predictive Insight To Operational Confidence In Complex Clinical TrialsAI-enabled precision medicine trials depend on strong data governance and security, enabling predictive operational intelligence while preserving human oversight and appropriate conventional analytics.
-
![GettyImages-944060504 coworkers computer]( "7 Silent Quality-Killers Of Clinical Trial Success")
7 Silent Quality-Killers Of Clinical Trial SuccessInvestigate seven hidden risks that quietly erode trial quality over time. Learn the early warning signs and how to catch and fix them before they escalate.
-
![Digital brain, AI, Machine Learning, AI Neural Network-GettyImages-2238702869]( "AI, Open Source, & the Future of Biostatistics")
AI, Open Source, & the Future of BiostatisticsAI and open-source tools are changing statistical programming. Learn how to validate, govern, and apply them without sacrificing the accuracy and oversight clinical research demands.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Stabilizing A Biotech Sponsor's Data Management And Biostatistics Functions8/29/2026
Discover how a rapid mid-study data transition rescued an endangered clinical trial, cleaned up compromised data, and secured a critical interim database lock within twelve months.
-
Driving ROI: A Real-Time Clinical Trial Oversight Solution8/3/2026
Sample errors, delays, and query overload drain clinical trial budgets. Learn how real-time data capture can shorten timelines and protect data quality.
-
Accelerating A Schizophrenia Trial While Ensuring Quality7/31/2026
Tight timelines and rising patient targets don't have to derail a trial. See how speed and data quality can work together from enrollment to database lock.
-
Reserving Data Integrity With Retrospective Manual Entry7/5/2026
A look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.
-
A Mission To Expand Recruitment Territory6/11/2026
Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.
CENTRAL LABORATORIES PRODUCTS & SERVICES
What can 22,000 people with an AI-mindset accomplish?
Speed without shortcuts
AI in clinical development at Parexel enables our teams to surface predictive insights at every stage, reducing protocol risk, study delays, and costly trial amendments.
Parexel's approach to AI in clinical development is built on the Precision Pathway, a strategic operating model that embeds AI across the full trial lifecycle. AI empowers our teams at critical decision points to:
- Simplify complex tasks to accelerate timelines: AI capabilities are delivering up to 50% cycle time reductions in IND submission generation.
- Apply insights with agility to enable better decision-making
- Enhance data handling to drive first-time quality through content generation and workflow automation
Expert Support for Clinical Research and Research Administration
Start getting accurate, high-quality, and timely biostatistics services delivered by this team of biostatisticians and statistical programmers, in addition to statistical planning, analysis, and reporting.
Patients shouldn’t have to jump through hoops. Discover an innovative portal that lets them handle travel and reimbursement directly—securely, simply, and without extra calls to the site.
Effortlessly distribute, monitor, and exchange study documents with every site—wherever they work, whenever they need it.
Other tools promise site connections, but they can't deliver 100% coverage with a solution sites actually want.
Adoption
They claim sites use their tool…but you need sites to love it.
Tracking
They let you send documents…but you need to know the status of every document at every site.
Integration
They offer integration within their ecosystem…but you need compatibility with every site and sponsor software.
Shape crucial market choices and value substantiation with the depth and breadth of integrated clinical EHRs, claims, and patient reported outcome data, backed by analytical and therapy area expertise.
Trial@home, CHDR’s dedicated strategy for off-site clinical trials, enables investigators to collect information as trial participants go about their day to day activities.
Elevate Your Clinical Research Data Collection
CENTRAL LABORATORIES SOLUTIONS
- Leverage AI To Optimize Protocol Design & Study Start-Up
- Clinical Pharmacokinetics And Pharmacometrics
- NDA/MAA Preparation Survival Guide: Overcoming Data Analysis Hurdles
- Simplify The Complexities Of RWE Generation
- Powering Smarter Treatments And Healthier People
- Glioblastoma Multiforme
- Feasibility As A Service From Consulting & Analytics
- Real-World Data And Real-World Evidence
- The Next-Generation Of Clinical Trial Data Management And Operations
- Aligning Site And Patient Needs For Clinical Trial Success
VIDEOS
NEWS
- Quotient Sciences Proprietary AI-Enhanced Solution Optimizes Formulation In Clinical Study
- Avance Clinical Appoints Inaugural Chief Commercial Officer, Reinforcing Global Growth Strategy
- Ypsomed Opens Production Site In China
- Ypsomed Launches YpsoLoop As The First Autoinjector Platform Designed For Circularity
- Ypsomed Expands Offering For Clinical Studies
- Ypsomed Receives The Red Dot Design Award 2026 For YpsoLoop
- Ypsomed Receives FDA Clearance For SmartPilot
- Signant Health Acquires Ametris To Create An End-To-End eCOA And Wearables Platform
- Avance Clinical Announces Asia Pacific And Mainland China Expansion Ahead Of BIO International Convention 2026
- The Ottawa Hospital's Biotherapeutics Manufacturing Centre (BMC) Makes Breakthroughs Break Through As Boreal Biomanufacturing
- Suvoda Patient App Earns "Best Patient Relationship Management Solution" In 2026 MedTech Breakthrough Awards Program
- Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development
- Paradigm Health Announces Collaboration With The FDA To Transform Regulatory Review Of Clinical Trial Data
- Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery
- Suvoda Announces Agentic RTSM, Enabling The Reduction Of Clinical Trial Startup Timelines By Up To 80%
- Signant Health Enters Definitive Agreement To Acquire Ametris
- Crucial Data Solutions Expands TrialKit AI With Study Simulation And Validation Capabilities
- AI HealthTech Pioneer Biorce Opens U.S. Offices In Austin To Accelerate Global Expansion
- Signant Health Appoints Specialist Physician And Clinical Research Expert Dr. Graham C. Ellis As Clinical Vice President To Strengthen Metabolic Disease And Diabetes Trial Capabilities
- Suvoda Advances Clinical Trial Financial Planning With Support For Complex Multi-Payee Budgets
- Suvoda Named "Most Innovative Clinical Trial Technology Firm Of 2026"
- Avance Clinical Appoints Liahna Toy To Lead Global Early Phase Center Of Excellence
- Avance Clinical Strengthens Global Oncology Offering With Acquisition Of U.S-Based LumaBridge
- Health Equity Research Goes Global—Without Waiting For Perfect Data
- International Study Confirms Universal Digital Health Framework
- ISPOR Announces New Executive Director
- Quotient Sciences Extends Commercial Manufacturing Partnership For Ultra-Rare Disease Treatment
- Sygnature Discovery Unveils Strategic Rebrand To Cement Status As A Global Drug Discovery Partner
- Suvoda Sets New Standard For Streamlined Patient And Site Experience In Clinical Trials
- Suvoda IRT Named A Leader In Everest Group's RTSM PEAK Matrix®